rs797045034
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PS1PM2PP2PP3_StrongPP5_Very_Strong
The NM_001845.6(COL4A1):c.2662G>A(p.Gly888Arg) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin Lovd.
Frequency
Consequence
NM_001845.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A1 | NM_001845.6 | c.2662G>A | p.Gly888Arg | missense_variant | 33/52 | ENST00000375820.10 | NP_001836.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A1 | ENST00000375820.10 | c.2662G>A | p.Gly888Arg | missense_variant | 33/52 | 1 | NM_001845.6 | ENSP00000364979 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 25719457) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2019 | - - |
COL4A1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2024 | The COL4A1 c.2662G>A variant is predicted to result in the amino acid substitution p.Gly888Arg. This variant has been reported in patients with COL4A1 related disorders, and has been documented as a de novo finding (Meuwissen et al. 2015. PubMed ID: 25719457; Coste et al. 2022. PubMed ID: 35150448; https://www.ncbi.nlm.nih.gov/clinvar/variation/209141/). Glycine substitutions in the conserved triple helical domain of this gene are a frequent cause of disease, as seen in this patient (https://www.ncbi.nlm.nih.gov/books/NBK7046/). Of note, one other nucleotide change, causing the same missense alteration (c.2662G>C; p.Gly888Arg) has also been reported as a de novo finding in a patient with a COL4A1-related disease (Giorgio et al. 2015. PubMed ID: 25873210). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
Brain small vessel disease 1 with or without ocular anomalies Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 12, 2013 | Likely pathogenicity based on finding it once in our laboratory de novo in a 27-year-old female with cerebral palsy, cataracts, intellectual disability, and epilepsy - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at